# Special Edition: What's Next—CKD in Type 1 Diabetes—An Urgent Need for Therapies

Page: https://stenobird.com/podcast/doc-updates-200053/special-edition-what-s-next-ckd-in-type-1-diabetes-an-urgent-need-for-therapies
Text version: https://stenobird.com/podcast/doc-updates-200053/special-edition-what-s-next-ckd-in-type-1-diabetes-an-urgent-need-for-therapies.md
Podcast: [DOC Updates](https://stenobird.com/podcast/doc-updates-200053)
Published: 2026-07-07T16:59:00+00:00
Episode link: https://diabetescoreupdate.libsyn.com/special-edition-whats-nextckd-in-type-1-diabetesan-urgent-need-for-therapies
Audio file: https://traffic.libsyn.com/secure/diabetescoreupdate/Special-Edition-CKD-and-Type-1-Diabetes-July-2026.mp3?dest-id=159994
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/special-edition-what-s-next-ckd-in-type-1-diabetes-an-urgent-need-for-therapies
Duration seconds: 1698

## Resource

There is a fundamental link between diabetes and kidney care. But while there are many medications available to improve CKD outcomes in people with type 2 diabetes, the same options are not available for people with type 1. In this special episode, Dr. Neil Skolnik speaks with Janet McGill, MD, MA, FACE, FACP about the underdiscussed prevalence of CKD in type 1 and the importance of continued development in this area. This special episode is sponsored with support from Bayer . Please listen to the episodes by clicking on the podcast player below or by freely subscribing to Diabetes Core Update via Apple Podcasts , Amazon Music , Spotify , or your preferred podcast platform. Presented by: Neil Skolnik , MD, Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University; Associate Director, Family Medicine Residency Program, Abington Jefferson Health Janet B. McGill , MD, MA, FACE, FACP, Professor of Medicine at the University of Washington's John T. Milliken Department of Medicine, Division of Endocrinology, Metabolism, and Lipid Research Selected References: Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 . The American Diabetes Association's Standards of Care 2026, Diabetes Care 2026;49 (Supplement_1):S246–S260 Finerenone in Type 1 Diabetes and Chronic Kidney Disease . N Engl J Med 2026;394:947-957 Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes . N Engl J Med 2020;383:2219-2229 Dapagliflozin in Patients with Chronic Kidney Disease . N Engl J Med 2020;383:1436-1446 Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes . N Engl J Med 2024;391:109-121

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/doc-updates-200053/episodes/special-edition-what-s-next-ckd-in-type-1-diabetes-an-urgent-need-for-therapies/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/doc-updates-200053/special-edition-what-s-next-ckd-in-type-1-diabetes-an-urgent-need-for-therapies.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.